Assessing quality of life in patients with colorectal cancer: An update of the EORTC quality of life questionnaire
Sameer Gujral(Bristol Royal Infirmary), Jane Blazeby(University Hospitals Bristol NHS Foundation Trust), Thierry Conroy(Inserm), Kerry Avery(University of Bristol), Orhan Sezer(Charité - Universitätsmedizin Berlin), Mag Sprangers(University of Amsterdam), Michael Koller(University Hospital Regensburg), P. A. Sylvester(Bristol Royal Infirmary), P. M. King(Bristol Royal Infirmary), Claudia Fleissner(Charité - Universitätsmedizin Berlin)
Cited by 216
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
|Journal of Clinical Oncology|2011|2.1k
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
|Journal of Clinical Oncology|2006|1.7k
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
|American Journal of Hematology|2005|1.4k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k